FormFactor Targets $400M Probe Card Capacity by 2027 Amid AI-Driven Demand

What happened

FormFactor's Q3 2026 earnings call revealed a specific target of $400 million in annual probe card capacity by 2027, driven by AI-driven chip testing demand, manufacturing improvements, and photonics growth. This builds on the company's previously disclosed Texas factory expansion and restructuring plan, adding a concrete number to the capacity ramp narrative. The call likely reaffirmed strong demand from AI and HBM-related probe cards, consistent with the growth seen in FQ1'26. However, the article from Zacks is promotional in nature and omits critical details on tariffs, restructuring charges, and the timing of the HBM4 ramp that were flagged as risks in the prior deep value report. Management's upbeat tone on capacity expansion does not by itself resolve the execution and valuation concerns previously identified.

Implication

The $400 million capacity target indicates management's confidence in sustained demand, but the market may have already priced in much of this optimism given the stock's high valuation multiples. Key watchpoints remain actual delivery of FQ2'26 guidance, Texas factory ramp progress, and margin improvement trajectory, which were not addressed in the article. Failure to meet these targets could lead to a sharp de-rating, while successful execution could justify higher long-term earnings. Investors should seek confirmation of the capacity ramp and margin expansion before adding exposure, preferring a pullback to a more attractive entry point. The balance sheet remains strong, but valuation risk dominates and a WAIT stance is still appropriate.

Thesis delta

The new information adds a specific capacity expansion target of $400 million annual probe card capacity by 2027, which slightly strengthens the long-term growth optionality underpinning the bull scenario. However, it does not change the near-term thesis of WAIT, as the capacity target is only a plan and lacks evidence of execution or impact on near-term financials. The core concerns of limited backlog visibility, margin headwinds, and high valuation remain unchanged.